FDA accepts Bayer's application for KERENDIA in chronic kidney disease without diabetes

Boehringer Ingelheim announces availability of new Quarterable Snap-Tab design for PREVICOX (firocoxib) Chewable Tablets

Okami Medical receives FDA approval for expanded indication of LOBO Vascular Occluder

Kedrion to be honoured at Premier's Supplier Innovation Celebration

Enliven Therapeutics reaches FDA alignment on relcobatinib (ELVN-001) Phase 3 trial design for previously treated CML

Zydus and MSN announce US launch of generic Adempas (Riociguat Tablets)

FDA approves second Reykjavik manufacturing suite for AVT02

Ractigen Therapeutics reports positive first-in-human data for RAG-18 in Duchenne muscular dystrophy

AnnJi Pharmaceutical's AJ201 advances into pivotal Phase 3 trial for SBMA

Teva reports new ecopipam data showing tic reduction in Tourette syndrome

PearlMatrix P-15 Peptide Enhanced Bone Graft receives Medicare New Technology Add-on Payment (NTAP) status

Genentech's fenebrutinib receives FDA priority review for multiple sclerosis

DBV Technologies submits FDA application for VIASKIN Peanut Patch in children

UTR Therapeutics' UTRxMYCN M1-14 receives US FDA Orphan Drug Designation and Rare Pediatric Disease Designation

Vanda Pharmaceuticals reports positive Phase III results for HETLIOZ in Delayed Sleep-Wake Phase Disorder